What Are the Main Limitations of Current Retatrutide Research?
Retatrutide is a synthetic peptide studied for its combined activity at glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP) and glucagon receptors. Published clinical studies have reported substantial changes in body weight and metabolic measurements. However, these findings need to be interpreted alongside the limitations of the available evidence. A positive result in a clinical trial […]
